Revelation Biosciences, Inc. (REVB)
USD 0.34
(1.75%)
USD 0.34
(1.75%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -7.28 Million | -11.21 Million | -11.09 Million | -215.07 Thousand | - |
| Net Income | -120.25 Thousand | -10.82 Million | -11.98 Million | -1.63 Million | -3638.00 |
| Depreciation & Amortization | 25.04 Thousand | 25.04 Thousand | 16.78 Thousand | - | - |
| Deferred income taxes | -749.66 Thousand | - | - | - | - |
| Stock-based compensation | 155.72 Thousand | 301.11 Thousand | 470.87 Thousand | 43.84 Thousand | - |
| Change in working capital | 982.13 Thousand | -730.97 Thousand | 356.22 Thousand | -80.49 Thousand | 3638.00 |
| Other non-cash items | -7.57 Million | 14.96 Thousand | 52.38 Thousand | 1.49 Million | - |
| Investing Cash Flow | - | - | -131.96 Thousand | -74.03 Million | - |
| Investments in PPE | -4.00 | - | -131.96 Thousand | - | - |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | - | - | -74.03 Million | - |
| Sales/Maturities of investments | - | - | 525.28 Thousand | - | - |
| Other Investing Activities | - | - | -525.28 Thousand | -74.03 Million | - |
| Financing Cash Flow | 14.02 Million | 15.19 Million | 8 Million | 74.26 Million | - |
| Debt repayment | - | -796.88 Thousand | - | -15 Thousand | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | -5000.00 | -7.65 Million | - | - | - |
| Common Stock Issuance | 14.03 Million | 4.46 Million | 8 Million | 74.24 Million | -10 Thousand |
| Other Financing Activities | 14.02 Million | 23.64 Million | 8 Million | 8.86 Million | 10 Thousand |
| Accounts receivables | - | - | - | - | - |
| Accounts payables | 749.66 Thousand | -666.04 Thousand | -269.64 Thousand | 30.13 Thousand | - |
| Inventory | - | - | - | - | - |
| Other working capital | 232.47 Thousand | -64.92 Thousand | 625.86 Thousand | -80.49 Thousand | 3638.00 |
| Cash at beginning of period | 5.25 Million | 1.27 Million | 4.49 Million | 74.24 Million | - |
| Cash at end of period | 11.99 Million | 5.25 Million | 1.27 Million | 11.73 Thousand | - |
| Capital Expenditure | -4.00 | - | -131.96 Thousand | - | - |
| Effect of forex changes on cash | - | - | - | -74.24 Million | - |
| Net cash flow / Change in cash | 6.73 Million | 3.97 Million | -3.21 Million | -74.23 Million | - |
| Free Cash Flow | -7.28 Million | -11.21 Million | -11.22 Million | -215.07 Thousand | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -8.38 Million | -2.68 Million | -2.2 Million | -120.25 Thousand | -2.62 Million | -1.44 Million |
| Depreciation & Amortization | 7220.00 | 6262.00 | 6262.00 | 25.04 Thousand | 6262.00 | 6262.00 |
| Deferred income taxes | - | - | -15.89 Thousand | -749.66 Thousand | -62.96 Thousand | - |
| Stock-based compensation | 57.09 Thousand | 32.09 Thousand | 32.09 Thousand | 155.72 Thousand | 32.09 Thousand | 59.43 Thousand |
| Change in working capital | 5.85 Million | -126.46 Thousand | 229.91 Thousand | 982.13 Thousand | 965.89 Thousand | -185.9 Thousand |
| Other non-cash items | 467.46 Thousand | -345.57 Thousand | -52.3 Thousand | -7.57 Million | -29.6 Thousand | -423.23 Thousand |
| Investing Cash Flow | -301.13 Thousand | -19.17 Thousand | - | - | - | - |
| Investments in PPE | -19.17 Thousand | -19.17 Thousand | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | -281.96 Thousand | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 5.41 Million | 5.41 Million | - | 14.02 Million | - | 15.00 |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | 5000.00 | -5000.00 | - | - |
| Common Stock Issuance | 25 Thousand | 5.41 Million | -14.02 Million | 14.03 Million | - | 15.00 |
| Other Financing Activities | 5.39 Million | -852.5 Thousand | 14.02 Million | 14.02 Million | - | 15.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -400.34 Thousand | 321.76 Thousand | 28.72 Thousand | 749.66 Thousand | 343.35 Thousand | 208.77 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 6.25 Million | -448.23 Thousand | 201.18 Thousand | 232.47 Thousand | 622.54 Thousand | -394.68 Thousand |
| Cash at beginning of period | 14.55 Million | 11.99 Million | 13.99 Million | 5.25 Million | 15.71 Million | 17.7 Million |
| Cash at end of period | 12.07 Million | 14.55 Million | 11.99 Million | 11.99 Million | 13.99 Million | 15.71 Million |
| Capital Expenditure | -19.17 Thousand | -19.17 Thousand | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -2.47 Million | 2.56 Million | -2 Million | 6.73 Million | -1.71 Million | -1.99 Million |
| Free Cash Flow | -2.49 Million | -2.85 Million | -2 Million | -7.28 Million | -1.71 Million | -1.99 Million |
KOCMT
LOVABLE
UNITECH
CERGF
PAR
1522